FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912783332> ?p ?o ?g. }

• W2912783332 endingPage "973" @default.
• W2912783332 startingPage "963" @default.
• W2912783332 abstract "•Sepsis activates hepatic PPARα. •PPARα plays a protective role in sepsis. •Pparα-deficiency impairs FA utilization in the liver during sepsis. •Hepatocyte Pparα-deficiency worsens the outcome of bacterial infection. •PPARα activity is lower in livers of non-surviving critically ill patients. Background & Aims Although the role of inflammation to combat infection is known, the contribution of metabolic changes in response to sepsis is poorly understood. Sepsis induces the release of lipid mediators, many of which activate nuclear receptors such as the peroxisome proliferator-activated receptor (PPAR)α, which controls both lipid metabolism and inflammation. We aimed to elucidate the previously unknown role of hepatic PPARα in the response to sepsis. Methods Sepsis was induced by intraperitoneal injection of Escherichia coli in different models of cell-specific Ppara-deficiency and their controls. The systemic and hepatic metabolic response was analyzed using biochemical, transcriptomic and functional assays. PPARα expression was analyzed in livers from elective surgery and critically ill patients and correlated with hepatic gene expression and blood parameters. Results Both whole body and non-hematopoietic Ppara-deficiency in mice decreased survival upon bacterial infection. Livers of septic Ppara-deficient mice displayed an impaired metabolic shift from glucose to lipid utilization resulting in more severe hypoglycemia, impaired induction of hyperketonemia and increased steatosis due to lower expression of genes involved in fatty acid catabolism and ketogenesis. Hepatocyte-specific deletion of PPARα impaired the metabolic response to sepsis and was sufficient to decrease survival upon bacterial infection. Hepatic PPARA expression was lower in critically ill patients and correlated positively with expression of lipid metabolism genes, but not with systemic inflammatory markers. Conclusion During sepsis, Ppara-deficiency in hepatocytes is deleterious as it impairs the adaptive metabolic shift from glucose to FA utilization. Metabolic control by PPARα in hepatocytes plays a key role in the host defense against infection. Lay summary As the main cause of death in critically ill patients, sepsis remains a major health issue lacking efficacious therapies. While current clinical literature suggests an important role for inflammation, metabolic aspects of sepsis have mostly been overlooked. Here, we show that mice with an impaired metabolic response, due to deficiency of the nuclear receptor PPARα in the liver, exhibit enhanced mortality upon bacterial infection despite a similar inflammatory response, suggesting that metabolic interventions may be a viable strategy for improving sepsis outcomes. Although the role of inflammation to combat infection is known, the contribution of metabolic changes in response to sepsis is poorly understood. Sepsis induces the release of lipid mediators, many of which activate nuclear receptors such as the peroxisome proliferator-activated receptor (PPAR)α, which controls both lipid metabolism and inflammation. We aimed to elucidate the previously unknown role of hepatic PPARα in the response to sepsis. Sepsis was induced by intraperitoneal injection of Escherichia coli in different models of cell-specific Ppara-deficiency and their controls. The systemic and hepatic metabolic response was analyzed using biochemical, transcriptomic and functional assays. PPARα expression was analyzed in livers from elective surgery and critically ill patients and correlated with hepatic gene expression and blood parameters. Both whole body and non-hematopoietic Ppara-deficiency in mice decreased survival upon bacterial infection. Livers of septic Ppara-deficient mice displayed an impaired metabolic shift from glucose to lipid utilization resulting in more severe hypoglycemia, impaired induction of hyperketonemia and increased steatosis due to lower expression of genes involved in fatty acid catabolism and ketogenesis. Hepatocyte-specific deletion of PPARα impaired the metabolic response to sepsis and was sufficient to decrease survival upon bacterial infection. Hepatic PPARA expression was lower in critically ill patients and correlated positively with expression of lipid metabolism genes, but not with systemic inflammatory markers. During sepsis, Ppara-deficiency in hepatocytes is deleterious as it impairs the adaptive metabolic shift from glucose to FA utilization. Metabolic control by PPARα in hepatocytes plays a key role in the host defense against infection." @default.
• W2912783332 created "2019-02-21" @default.
• W2912783332 creator A5001127450 @default.
• W2912783332 creator A5001525881 @default.
• W2912783332 creator A5005521737 @default.
• W2912783332 creator A5007224930 @default.
• W2912783332 creator A5008432179 @default.
• W2912783332 creator A5010711280 @default.
• W2912783332 creator A5013140552 @default.
• W2912783332 creator A5023719156 @default.
• W2912783332 creator A5026393485 @default.
• W2912783332 creator A5035530316 @default.
• W2912783332 creator A5036090523 @default.
• W2912783332 creator A5037086101 @default.
• W2912783332 creator A5040426633 @default.
• W2912783332 creator A5042145557 @default.
• W2912783332 creator A5045540534 @default.
• W2912783332 creator A5045821795 @default.
• W2912783332 creator A5047135384 @default.
• W2912783332 creator A5047653403 @default.
• W2912783332 creator A5050131069 @default.
• W2912783332 creator A5053244255 @default.
• W2912783332 creator A5053975880 @default.
• W2912783332 creator A5059870179 @default.
• W2912783332 creator A5065089185 @default.
• W2912783332 creator A5072446194 @default.
• W2912783332 creator A5074042132 @default.
• W2912783332 creator A5076062322 @default.
• W2912783332 creator A5080818741 @default.
• W2912783332 creator A5084831836 @default.
• W2912783332 creator A5087151365 @default.
• W2912783332 creator A5090721806 @default.
• W2912783332 date "2019-05-01" @default.
• W2912783332 modified "2023-10-18" @default.
• W2912783332 title "Hepatic PPARα is critical in the metabolic adaptation to sepsis" @default.
• W2912783332 cites W125300894 @default.
• W2912783332 cites W1603054792 @default.
• W2912783332 cites W1671834350 @default.
• W2912783332 cites W1969819718 @default.
• W2912783332 cites W1975962309 @default.
• W2912783332 cites W1980717583 @default.
• W2912783332 cites W2017948700 @default.
• W2912783332 cites W2035618305 @default.
• W2912783332 cites W2046887127 @default.
• W2912783332 cites W2047593217 @default.
• W2912783332 cites W2055447291 @default.
• W2912783332 cites W2080196545 @default.
• W2912783332 cites W2082811006 @default.
• W2912783332 cites W2087897497 @default.
• W2912783332 cites W2094572398 @default.
• W2912783332 cites W2095897782 @default.
• W2912783332 cites W2103116278 @default.
• W2912783332 cites W2104224178 @default.
• W2912783332 cites W2117520303 @default.
• W2912783332 cites W2119171159 @default.
• W2912783332 cites W2120024428 @default.
• W2912783332 cites W2120724780 @default.
• W2912783332 cites W2121914083 @default.
• W2912783332 cites W2123404136 @default.
• W2912783332 cites W2141151213 @default.
• W2912783332 cites W2148708580 @default.
• W2912783332 cites W2151529496 @default.
• W2912783332 cites W2160167304 @default.
• W2912783332 cites W2160933524 @default.
• W2912783332 cites W2162310928 @default.
• W2912783332 cites W2164990391 @default.
• W2912783332 cites W2167763455 @default.
• W2912783332 cites W2171774575 @default.
• W2912783332 cites W2216566996 @default.
• W2912783332 cites W2257770802 @default.
• W2912783332 cites W2321730038 @default.
• W2912783332 cites W2513994159 @default.
• W2912783332 cites W2550412681 @default.
• W2912783332 cites W2576499325 @default.
• W2912783332 cites W2602059628 @default.
• W2912783332 cites W2784412824 @default.
• W2912783332 cites W3099018540 @default.
• W2912783332 doi "https://doi.org/10.1016/j.jhep.2018.12.037" @default.
• W2912783332 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6774768" @default.
• W2912783332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30677458" @default.
• W2912783332 hasPublicationYear "2019" @default.
• W2912783332 type Work @default.
• W2912783332 sameAs 2912783332 @default.
• W2912783332 citedByCount "48" @default.
• W2912783332 countsByYear W29127833322019 @default.
• W2912783332 countsByYear W29127833322020 @default.
• W2912783332 countsByYear W29127833322021 @default.
• W2912783332 countsByYear W29127833322022 @default.
• W2912783332 countsByYear W29127833322023 @default.
• W2912783332 crossrefType "journal-article" @default.
• W2912783332 hasAuthorship W2912783332A5001127450 @default.
• W2912783332 hasAuthorship W2912783332A5001525881 @default.
• W2912783332 hasAuthorship W2912783332A5005521737 @default.
• W2912783332 hasAuthorship W2912783332A5007224930 @default.
• W2912783332 hasAuthorship W2912783332A5008432179 @default.
• W2912783332 hasAuthorship W2912783332A5010711280 @default.
• W2912783332 hasAuthorship W2912783332A5013140552 @default.
• W2912783332 hasAuthorship W2912783332A5023719156 @default.

• next